首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷核子醫學

市場調查報告書

商品編碼

1550639

核子醫學中的放射性藥物市場：按產品類型、按應用、按最終用戶、按地區

Radiopharmaceuticals in Nuclear Medicine Market, By Product Type, By Application, By End User, By Geography

出版日期: 2024年07月31日 | 出版商:

Coherent Market Insights | 英文 304 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

核醫放射性藥物的全球市場規模預計到2024年為71億美元，預計到2031年將達到126億美元，2024年至2031年的複合年成長率為8.5%。

報告範圍		報告詳情
基準年	2023年	2024年市場規模	71億美元
實際資料	2019-2023	預測期	2024年至2031年
預測 2024-2031 年複合年成長率：	8.50%	2031年價值預測	126億美元

圖：2024 年按地區分類的核醫放射性藥物市場佔有率

放射性藥物是核子醫學中用於診斷和治療目的的放射性藥物。放射性藥物透過從引入體內的放射性示蹤劑發射伽馬射線等核輻射，在醫學影像技術中發揮重要作用。放射性藥物是附著在生物活性藥物化合物（例如單株抗體）上的放射性同位素，選擇性地針對組織、器官和細胞。透過在掃描過程中與伽馬攝影機交互，醫生可以非侵入性地獲得代謝、生理和解剖細節的功能洞察。慢性病盛行率的上升、容易罹患癌症和心臟病的老年人口的增加以及放射性示蹤劑的技術進步可能會推動放射性藥物市場的成長。

市場動態：

對疾病早期診斷的需求不斷成長、有利的報銷政策、醫療保健支出的增加、對核醫學治療益處的認知等將推動核醫放射性藥物市場的發展。然而，由於放射性示蹤劑的半衰期短，對現場製造設施的需求以及高昂的設備安裝和維護成本可能會阻礙市場成長。透過研發合作開發用於神經病學、罕見疾病和個人化醫療的新型放射性示蹤劑可以提供成長機會。此外，藥物開發和標靶放射治療等新興市場的開拓也可能成為市場成長的驅動力。

本研究的主要特點

該報告對核醫放射性藥物的全球市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
該報告根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，提供了全球核醫放射性藥物市場主要企業的概況。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
核醫放射性藥物全球市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球核醫放射性藥物市場的各種策略矩陣，將有助於相關人員做出決策。

公司簡介
- Progenics Pharmaceuticals, Inc.
- NorthStar Medical Radioisotopes LLC
- Curium Pharma
- Life Molecular Imaging
- Lantheus Holdings, Inc.
- Cardinal Health, Inc.
- General Electric Company
- Bracco SpA
- Bayer AG
- GE Healthcare
- Jubilant Pharmova Limited
- Eckert &Ziegler
- Mallinckrodt
- NTP Radioisotopes SOC Ltd.
- Telix Pharmaceuticals, Inc.
- Nordic Nanovector
- Y-mAbs Therapeutics, Inc.
- Siemens Healthineers AG

第10章分析師建議

命運之輪
分析師觀點
一致的機會圖

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI70

Global radiopharmaceuticals in nuclear medicine market is estimated to be valued at USD 7.10 Bn in 2024 and is expected to reach USD 12.6 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.5% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 7.10 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	8.50%	2031 Value Projection:	US$ 12.6 Bn

Figure. Radiopharmaceuticals in Nuclear Medicine Market Share (%), By Region 2024

Radiopharmaceuticals in Nuclear Medicine Market - IMG1

Radiopharmaceuticals are radioactive drugs used in nuclear medicine for both diagnostics and therapeutics purposes. These play a crucial role in medical imaging techniques through emission of nuclear radiation such as gamma rays from radioactive tracers introduced into the body. Radiopharmaceuticals consist of radioactive isotopes bonded to bioactive pharmaceutical compounds like monoclonal antibodies to selectively target tissues, organs or cells. On interaction with gamma cameras during scans, these help physicians gain functional insights into metabolic, physiological and anatomical details non-invasively. Rising prevalence of chronic diseases, growing geriatric population susceptible to cancer and cardiac ailments and technological advancements in radiotracers can drive the growth of radiopharmaceuticals market.

Market Dynamics:

Surging demand for early disease diagnosis, favorable reimbursement policies, increasing healthcare expenditure, and awareness about benefits of nuclear medicine procedures can drive the radiopharmaceuticals in nuclear medicine market. However, short half-lives of radiotracers requiring on-site production facilities and high installation and maintenance costs of equipment can hamper the market growth. Developing new radiotracers for neurology, rare diseases and personalized medicine through R&D collaborations can offer growth opportunities. Emerging applications in drug development and targeted radiotherapy can also drive the market growth.

Key Features of the Study:

This report provides in-depth analysis of the global radiopharmaceuticals in nuclear medicine market, and provides market size (USD billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global radiopharmaceuticals in nuclear medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GE Healthcare, Bracco Imaging S.p.A., Lantheus Medical Imaging Inc., Bayer AG, Novartis AG (Advanced Accelerator Applications), Nordion Inc., and Jubilant DraxImage Inc. dba Jubilant Radiopharma
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global radiopharmaceuticals in nuclear medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radiopharmaceuticals in nuclear medicine market

Detailed Segmentation-

By Product Type
- Diagnostic Nuclear Medicine
- SPECT Radiopharmaceuticals
- PET Radiopharmaceuticals
- Therapeutic Nuclear Medicine
By Application
- Oncology
- Cardiology
- Neurology
- Endocrinology
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Diagnostic Centers
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Progenics Pharmaceuticals, Inc.
- NorthStar Medical Radioisotopes LLC
- Curium Pharma
- Life Molecular Imaging
- Lantheus Holdings, Inc.
- Cardinal Health, Inc.
- General Electric Company
- Bracco S.p.A.
- Bayer AG
- GE Healthcare
- Jubilant Pharmova Limited
- Eckert & Ziegler
- Mallinckrodt
- NTP Radioisotopes SOC Ltd.
- Telix Pharmaceuticals, Inc.
- Nordic Nanovector
- Y-mAbs Therapeutics, Inc.
- Siemens Healthineers AG

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Radiopharmaceuticals in Nuclear Medicine Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Radiopharmaceuticals in Nuclear Medicine Market, By Product Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Diagnostic Nuclear Medicine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
SPECT Radiopharmaceuticals
PET Radiopharmaceuticals
Therapeutic Nuclear Medicine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Radiopharmaceuticals in Nuclear Medicine Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cardiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Neurology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Endocrinology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Radiopharmaceuticals in Nuclear Medicine Market, By End User, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ambulatory Surgical Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Diagnostic Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Radiopharmaceuticals in Nuclear Medicine Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Progenics Pharmaceuticals, Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- NorthStar Medical Radioisotopes LLC
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Curium Pharma
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Life Molecular Imaging
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Lantheus Holdings, Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cardinal Health, Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- General Electric Company
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bracco S.p.A.
- Bayer AG
- GE Healthcare
- Jubilant Pharmova Limited
- Eckert & Ziegler
- Mallinckrodt
- NTP Radioisotopes SOC Ltd.
- Telix Pharmaceuticals, Inc.
- Nordic Nanovector
- Y-mAbs Therapeutics, Inc.
- Siemens Healthineers AG